Wroclaw, Poland

Bogdan Boduszek


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bogdan Boduszek

Introduction

Bogdan Boduszek is a notable inventor based in Wroclaw, Poland. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential therapeutic applications. With a total of two patents to his name, Boduszek's work focuses on innovative solutions that address critical health issues.

Latest Patents

Boduszek's latest patents include groundbreaking research on Basic α-aminoalkylphosphonate derivatives. These peptidyl derivatives of diesters of α-aminoalkylphosphonic acids are designed to inhibit serine proteases with trypsin-like specificity. They also serve as anti-inflammatory agents, anticoagulants, and anti-tumor agents. Another significant patent involves Proline phosphonate derivatives, which are peptidyl derivatives of diesters of α-aminoalkylphosphonic acids, particularly those with proline or related structures. These derivatives are aimed at inhibiting serine proteases with various specificities and also play roles as anti-inflammatory agents, anticoagulants, and anti-tumor agents.

Career Highlights

Boduszek is affiliated with the Georgia Tech Research Corporation, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on medical treatments and therapeutic strategies.

Collaborations

Some of his notable coworkers include James C Powers and Jozef Oleksyszyn, who contribute to the collaborative efforts in research and development within their field.

Conclusion

Bogdan Boduszek's contributions to the field of chemistry through his innovative patents highlight his commitment to advancing medical science. His work not only showcases his expertise but also emphasizes the importance of collaboration in achieving significant breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…